AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes

NCT01720290 ·Status: COMPLETED ·Phase: PHASE4

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

NCT00399711 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes

NCT04943692 ·Status: SUSPENDED ·Phase: PHASE3

Avandamet Bioequivalence Study Brazil - Fed Administration

NCT01332071 ·Status: COMPLETED ·Phase: PHASE1

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

NCT00361738 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes

NCT01465152 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers

NCT01560481 ·Status: COMPLETED ·Phase: PHASE1

Extension Study for 2993-112

NCT01789957 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)

NCT00792935 ·Status: COMPLETED ·Phase: PHASE2

Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients

NCT00940472 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

NCT01245166 ·Status: UNKNOWN ·Phase: PHASE3

Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs

NCT00819741 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes

NCT00568984 ·Status: COMPLETED ·Phase: PHASE4

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

NCT00519142 ·Status: COMPLETED ·Phase: PHASE3

A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)

NCT00873821 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin

NCT00970593 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin

NCT01540487 ·Status: COMPLETED ·Phase: PHASE1

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

NCT03349684 ·Status: COMPLETED ·Phase: PHASE3

Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)

NCT00032487 ·Status: COMPLETED ·Phase: PHASE3

A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED)

NCT00912002 ·Status: COMPLETED ·Phase: PHASE1

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

NCT00961909 ·Status: COMPLETED ·Phase: PHASE1

Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients

NCT02151461 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

NCT00944346 ·Status: COMPLETED ·Phase: PHASE1

Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions

NCT00832481 ·Status: UNKNOWN ·Phase: NA

A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib

NCT01551615 ·Status: COMPLETED ·Phase: PHASE1